Scientists presented more than 45 abstracts that demonstrated the value of Bio-Rad’s Droplet Digital PCR (ddPCR) technology
The latest imaging system promises high-resolution, sensitivity and reliability in a compact system
The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19
Bio-Rad Laboratories has launched a range of anti-certolizumab pegol inhibitory antibodies to support the development of anti-drug antibody (ADA) assays
The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2
Test runs on Bio-Rad’s QX200 and QXDx ddPCR systems and aims to provide early detection of COVID-19
Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals
The Standard is said to contain synthetic COVID-19 RNA transcripts and human genomic DNA
The dd-Check STEC solution uses Droplet Digital PCR technology to check for genes associated with the STEC pathogen
The EDX RP Positive Run Control aims to monitor the performance of clinical respiratory assays
SEQuoia Complete Stranded RNA Library Prep Kit is designed to be a novel approach to RNA-Seq library preparation
This technology was showcased at the 2019 ASH Annual Meeting
Bio-Rad launches iQ-check real-time PCR kit for detection of Aspergillus in cannabis and cannabis-infused products
Bio-Rad introduces the Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay
High capture efficiency and sensitivity of scATAC-Seq assay demonstrated in Nature Biotechnology study
Bio-Rad’s Droplet Digital PCR (ddPCR)-powered liquid biopsy was presented during the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta
